Company intelligence / Profile preview

Altium

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Altium operates as an international supplier and distributor of advanced laboratory instruments, consumables, and service packages for academic, hospital, biotech, and pharmaceutical customers. It partners with innovative brands to bring disruptive lab technologies—such as 3D live cell imaging systems—to the US market. The company focuses on tailored sales strategies and long-term partnerships within the life sciences sector.

Industry: Drug Discovery Services

Partnerships

Tomocube’s HT Series (3D label-free live cell imaging)PHI AB’s Holomonitor (live cell analysis)CellDynamics W8 Physical Cytometer

Beyond the preview

Go deeper on Altium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altium.

Explore the full profile